# STOCKHOLM 1.0
#=GF ID   EthR_C
#=GF AC   PF21313.1
#=GF DE   Transcriptional regulator EthR, C-terminal domain
#=GF AU   Bateman A;0000-0002-6982-4660
#=GF AU   Chuguransky S;0000-0002-0520-0736
#=GF SE   ECOD:EF15566
#=GF GA   27.00 27.00;
#=GF TC   27.00 27.00;
#=GF NC   26.90 26.90;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -E 1000 --cpu 4 -Z 75585367 HMM pfamseq
#=GF TP   Domain
#=GF CL   CL0174
#=GF RC   Paper describing PDB structure 1t56
#=GF RN   [1]
#=GF RM   15236969
#=GF RT   Crystal structure of the TetR/CamR family repressor
#=GF RT   Mycobacterium tuberculosis EthR implicated in ethionamide
#=GF RT   resistance.
#=GF RA   Dover LG, Corsino PE, Daniels IR, Cocklin SL, Tatituri V, Besra
#=GF RA   GS, Futterer K;
#=GF RL   J Mol Biol. 2004;340:1095-1105.
#=GF RC   Paper describing PDB structure 1u9n
#=GF RN   [2]
#=GF RM   15494316
#=GF RT   Structure of EthR in a ligand bound conformation reveals
#=GF RT   therapeutic perspectives against tuberculosis.
#=GF RA   Frenois F, Engohang-Ndong J, Locht C, Baulard AR, Villeret V;
#=GF RL   Mol Cell. 2004;16:301-307.
#=GF RC   Paper describing PDB structure 3g1l
#=GF RN   [3]
#=GF RM   19412174
#=GF RT   Synthetic EthR inhibitors boost antituberculous activity of
#=GF RT   ethionamide.
#=GF RA   Willand N, Dirie B, Carette X, Bifani P, Singhal A, Desroses M,
#=GF RA   Leroux F, Willery E, Mathys V, Deprez-Poulain R, Delcroix G,
#=GF RA   Frenois F, Aumercier M, Locht C, Villeret V, Deprez B, Baulard
#=GF RA   AR;
#=GF RL   Nat Med. 2009;15:537-544.
#=GF RC   Paper describing PDB structure 3qpl
#=GF RN   [4]
#=GF RM   22156370
#=GF RT   Structural activation of the transcriptional repressor EthR from
#=GF RT   Mycobacterium tuberculosis by single amino acid change mimicking
#=GF RT   natural and synthetic ligands.
#=GF RA   Carette X, Blondiaux N, Willery E, Hoos S, Lecat-Guillet N, Lens
#=GF RA   Z, Wohlkonig A, Wintjens R, Soror SH, Frenois F, Dirie B,
#=GF RA   Villeret V, England P, Lippens G, Deprez B, Locht C, Willand N,
#=GF RA   Baulard AR;
#=GF RL   Nucleic Acids Res. 2012;40:3018-3030.
#=GF RC   Paper describing PDB structure 3sdg
#=GF RN   [5]
#=GF RM   22098589
#=GF RT   Ethionamide boosters. 2. Combining bioisosteric replacement and
#=GF RT   structure-based drug design to solve pharmacokinetic issues in a
#=GF RT   series of potent 1,2,4-oxadiazole EthR inhibitors.
#=GF RA   Flipo M, Desroses M, Lecat-Guillet N, Villemagne B, Blondiaux N,
#=GF RA   Leroux F, Piveteau C, Mathys V, Flament MP, Siepmann J, Villeret
#=GF RA   V, Wohlkonig A, Wintjens R, Soror SH, Christophe T, Jeon HK,
#=GF RA   Locht C, Brodin P, Deprez B, Baulard AR, Willand N;
#=GF RL   J Med Chem. 2012;55:68-83.
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   HTH-type transcriptional regulator EthR is involved in the
#=GF CC   repression of the monooxygenase EthA which is responsible of the
#=GF CC   formation of the active metabolite of ethionamide (ETH). It is
#=GF CC   responsible for the low sensitivity of the human pathogen
#=GF CC   Mycobacterium tuberculosis to ethionamide. It consists of a
#=GF CC   DNA-binding HTH domain at the N-terminal and a C-terminal
#=GF CC   helical domain that binds its ligand [1-5].
#=GF SQ   26
#=GS A0A0Q5LHW1_9MICO/104-214  AC A0A0Q5LHW1.1
#=GS A0A126Z5A2_9MICO/104-213  AC A0A126Z5A2.1
#=GS W5WFB8_9PSEU/101-211      AC W5WFB8.1
#=GS A0A076MU31_AMYME/102-211  AC A0A076MU31.1
#=GS H6RNE2_BLASD/102-212      AC H6RNE2.1
#=GS D9TDJ7_MICAI/103-212      AC D9TDJ7.1
#=GS A0A0Q4V2A0_9MICO/99-209   AC A0A0Q4V2A0.1
#=GS A0A0Q5CE37_9MICO/93-205   AC A0A0Q5CE37.1
#=GS A0A0N1GBD9_9ACTN/103-213  AC A0A0N1GBD9.1
#=GS A0A023X7U8_9ACTN/94-206   AC A0A023X7U8.1
#=GS A0A0Q7B5M5_9ACTN/86-195   AC A0A0Q7B5M5.1
#=GS A0A1A9GIW8_9ACTN/93-199   AC A0A1A9GIW8.1
#=GS A1TGZ9_MYCVP/111-221      AC A1TGZ9.1
#=GS I0RXT4_MYCXE/100-209      AC I0RXT4.1
#=GS ETHR_MYCTU/103-213        AC P9WMC1.1
#=GS A0A1A3N9N8_MYCAS/102-212  AC A0A1A3N9N8.1
#=GS A0A1A1ZAP3_9MYCO/99-209   AC A0A1A1ZAP3.1
#=GS A0A0G3IQH8_9MYCO/98-208   AC A0A0G3IQH8.1
#=GS A0A1E8Q7E0_9MYCO/101-210  AC A0A1E8Q7E0.1
#=GS W9AY68_MYCCO/100-210      AC W9AY68.1
#=GS A0A0D1JW18_9MYCO/100-210  AC A0A0D1JW18.1
#=GS F5YUE9_MYCSD/99-209       AC F5YUE9.1
#=GS A0A1A3Q2E4_9MYCO/100-210  AC A0A1A3Q2E4.1
#=GS K5BC73_MYCHD/102-211      AC K5BC73.1
#=GS G7CCU0_MYCT3/102-211      AC G7CCU0.1
#=GS A0A0I9TQK3_9MYCO/106-216  AC A0A0I9TQK3.1
A0A0Q5LHW1_9MICO/104-214             WRRAISAFFETFAAHPGVVAAVVGA.RGTD.AEIVAQWSRLLQGWIDETARAIEAERARGAAV...AGPEPRVLATSLNLLNERVIMAALT..EPSLPGAAVdpVDTLLHVWLSSIYG
A0A126Z5A2_9MICO/104-213             WRRAIEAFADTFAKHRGVSIAVAAAaRLSSeAELAAEWARLMGRWIDGTAAAIDAERARGAAI...DGPAAHDLATVLNQLNERVITVALAASREPRDE.....VDTLLHVWLTSIYG
W5WFB8_9PSEU/101-211                 WREAIGVFYETFGAHRAVTLAAAEV.QLSN.SEVRELWSKVMEGWASDTAALIEAERERGAAP...PGAPARDLAIALIRMNERMLHATFAGESPSVSEQDV..VEVLATIWLSTIYG
A0A076MU31_AMYME/102-211             WRQCLDAIYTTFRAHRSVALAAAEA.RHTN.AEVRELWAGMMGTWVSRTAEAIEAERARGAAP...AGRPARELAIALNLMNERVLYATFAGDDPAVLEANV..VDVLLDVWLTTIY.
H6RNE2_BLASD/102-212                 WARAIGAYYETFRAHRALTVAWAQA.RSAS.DEVRALWSAVFERWVQQCATAIDAERARGAAP...PGLPSRDLAVALTSMNERVLYATFSGDGPAIAESDV..VDVLLGIWLSAVYG
D9TDJ7_MICAI/103-212                 WRELIARFHATFGGHRDVVLACAQV.RGTN.AEVRRLWAEVLERWVRAVQAAIESERARGAAP...DGLPARDLAIALNSMNERVWYATFAGDGPAVAERDV..VDVLLDVWLTAIY.
A0A0Q4V2A0_9MICO/99-209              WRRSIGVFVDVFTTHRGVAAATATA.RLRN.AEVLTLWSASMRTWSDYATEVIRAERARGAAP...DGIDANELAVALNLMNERVLSAAFTGESPAIELDHA..LDVLTTIWLRAIYA
A0A0Q5CE37_9MICO/93-205              WRESIGVFVEVFSDHRAVSAAAVAA.RLRN.PEVHALWSKAMASWVDYSTEVIVAERARGAAPtgpQDLDARELAIALNLMNERALTAAFNGDSPAIDPGGI..LDVLAAVWLRAIY.
A0A0N1GBD9_9ACTN/103-213             WRDAIGPFCATFASHRAIASAAAAA.QYTS.AAVKDLWAQVMEQFVAEVTAAIESERRRGAAP...EGIPARDLAVSLNWMVERALFSTFGGQSPALAEDRL..LDTLVAVFMSAVYG
A0A023X7U8_9ACTN/94-206              WEEVIRGVFETWREHRTLMNAACEA.LSTS.PEVRRVWERTLEGFVDLTTRAIEDERERGAASg.gAGVPARDLATALNWANERMLYATFSGTSPAVPEDRL..VGVLVEMWLAAIYG
A0A0Q7B5M5_9ACTN/86-195              VTTAIRTIFRGWGDRIHLYRAMLEA.RATS.SAVRDQWDAYQASFITVVTAVIEGERTAGRAP...AGPDAHAVATALLDLNAQTLGR.LVHAPADFDWDRH..LEAVVHVWLTSIYG
A0A1A9GIW8_9ACTN/93-199              ..ATIRGVFASWDKHEHLCRATLEA.RATS.PAVRELWDSDRESFVPVVAAMIDEERAAGRAP...GGVPAATLATVLLELNDRMLERIAV.GGPLGRE.EL..VEGVVTVWLRTIYG
A1TGZ9_MYCVP/111-221                 WRRGINVFFETFGAHRAVCATTVGV.KSTN.SEARELWSRSMQRWIDHIAAVIEAERADGAAP...VTVPARELSTALNLMNESVMTATFTGHQPAIPDDRV..LDNLVHIWTTSIYG
I0RXT4_MYCXE/100-209                 WRTGINVFVETFSTHRAVSLAADAA.R.TN.EDVRELWSRFMQKWVAHAAAVIEAERARGAAP...VTLPAHDLSAALNLLNEKVMLASFADARPSVPDEHL..LDTLVHIWVTSIYG
ETHR_MYCTU/103-213                   WRTGINVFFETFGSHKAVTRAGQAA.RATS.VEVAELWSTFMQKWIAYTAAVIDAERDRGAAP...RTLPAHELATALNLMNERTLFASFAGEQPSVPEARV..LDTLVHIWVTSIYG
A0A1A3N9N8_MYCAS/102-212             WRLGINVFFQAFGSHKGVTRASMAA.RDTS.PEIRELWSTFMHKWIAFSAAGIEAERERGAAP...RTLPSQELATALNLMNERALFASFTAEQPSVPEARV..LDTLIHVWVSSIYG
A0A1A1ZAP3_9MYCO/99-209              WRSGIFGFFEPLRENLPVVLAGVAA.TSTN.AEIREMWSRFMQNWVDRTAAVITAERARGAAP...ETVPAQDLAAALNLMNERTMFASYTGQTPAIAEDAA..LDTLAHIWITSIYG
A0A0G3IQH8_9MYCO/98-208              WHDGIYAFFDSLRPHRAVVLAGLGV.MATN.TELQELWSGFMTGWIDYTAGLILRERERGAAP...GTIPAHDLATALNLMNERVMVAAQGSQQPALPEEAA..LEALAHIWITSIYG
A0A1E8Q7E0_9MYCO/101-210             .LEGIRTFFTAFGDHGVVARAGTEA.IAGS.PDVRAVWSAFMQKWITQTAALIEAERARGAAP...DTIPAHDLATTLNLMNERAMTATLVAEDGAVARDRI..VETLAHIWLTSIYG
W9AY68_MYCCO/100-210                 IRRGIEIFFSSFGSHPATARAGVEA.VTTS.PEFRAIWQGLMQKWIAMTAALIRVERERGAAP...ETISALDLATSLNLMNERTMMAALAGEQPAVEHDKV..VDTLTHIWLTSIYG
A0A0D1JW18_9MYCO/100-210             IRHGIEIFFSSFGSHPATARAGVEA.VRTV.PEFREVWAGLMQKWINLTAALITAERTRGAAP...ETLPARDLATSLNLMNERMIMATLAGEPGAVAHDDV..VNTLTHIWLNSIYS
F5YUE9_MYCSD/99-209                  WRSGIKAFFIAFSSHRAIARAGTEA.LATS.PEFKAMWNGFMQRWIQQTAAMITAERDRGAAP...RTIPALDLATSLNQMNERTMMAALIAEEPSVAHDRV..VDTLTHIWVSSIYG
A0A1A3Q2E4_9MYCO/100-210             WRAGIKAFFVAFDSHRAVARAGAEA.ISSS.AEVRAVWASFMQKWIDQTAALIVAERERGAAP...DTIPAIDLATSLNQMNERTMMAALSAEQPAVHHDRV..VDTLAHIWVTSIYG
K5BC73_MYCHD/102-211                 WQ.AINALFRTFGAHRAVTLAGAAA.RPNN.ADIQELWSRFMQKWIDHTAASIQAERDRGAAP...DTIPAADLAVSLNLMNERTMLAAFAAEQPAVSTERL..VDTLAHIWVTSIYG
G7CCU0_MYCT3/102-211                 WRA.INALFETFGAHRAVTLAGAAA.RTTN.TEVDALWSRFMKKWIDYTAESIRAERERGAAP...DTIPAEDLAVSLNLMNERTMFAAFADEKPAVPEDRI..VDTLAHIWLTSIYG
A0A0I9TQK3_9MYCO/106-216             WRAAITAFFEACGTHRAVAVAGAAA.KATN.PEVRQLWSKVMQQWIDYNTAAIKAERKRGAAP...DTVPAEDLAVALQLMTERVMAATFADEKPSIPEKKI..VDTLVHIWLASVYG
#=GC seq_cons                        WRpuIpsFFcoFusHRuVshAustA.+sTs.sEVRpLWuphMppWlshoAAsIcAERsRGAAP...sslPA+DLAsuLNLMNERshhAsauu-pPAls-ccl..VDsLsHIWLoSIYG
